Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Haran Schlamm
Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: A Dose Escalation Study
Journal of Clinical Pharmacology
Pharmacology
Related publications
A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination With Erlotinib in Patients With Advanced Solid Tumors
Oncologist
Cancer Research
Medicine
Oncology
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: A Randomized, Placebo-Controlled First-In-Human Single-Dose Escalation Study
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Steady-State Plasma Pharmacokinetics of Oral Voriconazole in Obese Adults
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Safety and Pharmacokinetics of MM-302, a HER2-targeted Antibody–liposomal Doxorubicin Conjugate, in Patients With Advanced HER2-positive Breast Cancer: A Phase 1 Dose-Escalation Study
British Journal of Cancer
Cancer Research
Oncology
Safety and Pharmacokinetics of Intravenous Anidulafungin in Children With Neutropenia at High Risk for Invasive Fungal Infections
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
First-In-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-In-Class Dual MEK/RAF Inhibitor in Patients With Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pharmacokinetics and Safety of a Single Dose of Stavudine (D4T) in Patients With Severe Hepatic Impairment.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
